0001127602-13-010800.txt : 20130314
0001127602-13-010800.hdr.sgml : 20130314
20130314163359
ACCESSION NUMBER: 0001127602-13-010800
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130312
FILED AS OF DATE: 20130314
DATE AS OF CHANGE: 20130314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BERGER HARVEY J M D
CENTRAL INDEX KEY: 0000932052
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21696
FILM NUMBER: 13690876
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2013-03-12
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0000932052
BERGER HARVEY J M D
C/O ARIAD PHARMACEUTICALS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
1
Chairman & CEO
Common Stock
2013-03-12
4
S
0
2700
22.0428
D
30157
I
Trust
Common Stock
2013-03-12
4
S
0
50000
22.0351
D
1726089
D
Common Stock
2013-03-13
4
S
0
2700
22.0694
D
27457
I
Trust
Common Stock
2013-03-13
4
S
0
50000
22.0598
D
1676089
D
Common Stock
246054
I
Daughter
Common Stock
248745
I
Daughter
Common Stock
1714286
I
Ocean Capital Partners, Llc
Common Stock
20251
I
Wife
This sale was effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.77 to $22.05, inclusive. The reporting person undertakes to provide to ARIAD Pharmaceuticals, Inc. ("ARIAD"), any security holder of ARIAD, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.84 to $22.26, inclusive. The reporting person undertakes to provide to ARIAD Pharmaceuticals, Inc. ("ARIAD"), any security holder of ARIAD, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.08 to $22.11, inclusive. The reporting person undertakes to provide to ARIAD Pharmaceuticals, Inc. ("ARIAD"), any security holder of ARIAD, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.02 to $22.13, inclusive. The reporting person undertakes to provide to ARIAD Pharmaceuticals, Inc. ("ARIAD"), any security holder of ARIAD, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
The reporting person is a managing member of this LLC.
/s/Edward M. Fitzgerald, Attorney-in-Fact
2013-03-14